Negative findings with nicotinic acid in the treatment of schizophrenias.
D000323:Adrenochrome / Q000097:blood; D002027:Bufotenin / Q000652:urine; D004118:Dimethoxyphenylethylamine / Q000652:urine; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008715:Methionine / Q000009:adverse effects / Q000627:therapeutic use; D008745:Methylation; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011736:Pyridoxine / Q000627:therapeutic use; D011758:Pyrroles / Q000097:blood; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism / Q000652:urine
D004118:Dimethoxyphenylethylamine; D009539:Nicotinic Acids; D010919:Placebos; D011758:Pyrroles; D002027:Bufotenin; D000323:Adrenochrome; D008715:Methionine; D011736:Pyridoxine